We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1024:HKEXREYON Pharmaceutical Co., Ltd. analysis

Data as of Oct 7, 2026 - not real-time

Latest price
HK$30.18
Risk: medium
6/10Medium risk

Summary

At HKD 30.18, Kuaishou Technology shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 8.6% over the past 30 days. Relative strength is 39.0 — approaching oversold — and the MACD signal is bullish. Recent trading has carved out support near HKD 28.84 and resistance around HKD 34.00.
Multiples put this in undervalued territory: 7.4 times earnings against the sector's 15.4. Sell-side targets cluster 58.1% above the current quote. The 2.34% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 31.8%, a beta of 0.34 and a maximum drawdown of 66.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 6 out of 10.

Top market events

  • Detailed price information for Kuaishou Technology B KUASF from The Globe and Mail including charting and trades.
  • Detailed price information for Kuaishou Technology B KUASF from The Globe and Mail including charting and trades.
  • Detailed price information for Kuaishou Technology B KUASF from The Globe and Mail including charting and trades.

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 50.77
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 7.4 versus sector average of 15.4
  • Trading below the 200-day average of 50.77

Long term

> 3 years

Positive

Model confidence6/106 out of 10

Key factors

  • P/E of 7.4 versus sector average of 15.4
  • Analyst targets imply +58.1% versus the current price
  • Return on equity of 20.6%

Key metrics

Financial health

Revenue Growth1.40%
Profit Margin10.92%
P/E Ratio7.4
ROE20.63%
ROA5.48%
Debt/Equity47.44
P/B Ratio1.4
Op. Cash FlowHK$24.0B
Free Cash FlowHK$16.0B
Industry P/E15.4

Technical analysis

TrendBearish
RSI39.0
SupportHK$28.84
ResistanceHK$34.00
MA 20HK$30.67
MA 50HK$35.47
MA 200HK$50.77
MACDBullish
VolumeDecreasing
Fear & Greed Index94.63

Valuation

Fair ValueHK$56.13
Target PriceHK$47.71
Upside/Downside58.09%
GradeUndervalued
TypeValue
Dividend Yield2.34%

Risk assessment

Beta0.34
Volatility31.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.